L

Locus Biosciences, Inc.

66 employees

Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.

Basic info

Industry

biotechnology research

Sectors

CRISPR
Biotechnology
Bacterial Infections
Therapeutics
Antibiotic Resistance
Biopharma
Targeted Therapeutics
Microbiome

Date founded

2015

Funding rounds raised

Total raised

$35M

from 13 investors over 13 rounds

L

Locus Biosciences, Inc. raised $35M on May 18, 2022

Investors: ARTIS Ventures, Tencent and Viking Global Investors

L

Locus Biosciences, Inc. raised $25M on October 19, 2021

Investors: Hercules Capital, Inc.

L

Locus Biosciences, Inc. raised $13M on November 10, 2020

Investors: CARB-X

L

Locus Biosciences, Inc. raised $3K on August 4, 2020

Investors: North Carolina Biotechnology Center (NCBiotech)

L

Locus Biosciences, Inc. raised $19M on November 14, 2017

Investors: Tencent, North Carolina Biotechnology Center (NCBiotech), ARTIS Ventures, Starlight Ventures and Abstract Ventures

L

Locus Biosciences, Inc. raised $5M on July 10, 2017

Investors: Tencent and North Carolina Biotechnology Center (NCBiotech)

FAQ